Buspirone Side Effects
Buspirone's most common side effects include dizziness (12%), nausea (8%), headache (6%), nervousness (5%), and lightheadedness (3%), with approximately 10% of patients discontinuing treatment due to adverse events, primarily CNS disturbances. 1
Most Common Side Effects (≥1% incidence)
The FDA-approved labeling identifies the following side effects occurring at higher rates than placebo in controlled trials 1:
Central Nervous System Effects
- Dizziness (12%) - most frequent side effect 1
- Drowsiness (10%) 1
- Nervousness (5%) 1
- Insomnia (3%) 1
- Lightheadedness (3%) 1
- Decreased concentration (2%) 1
- Excitement (2%) 1
- Anger/hostility (2%) 1
- Confusion (2%) 1
- Depression (2%) 1
Gastrointestinal Effects
- Nausea (8%) - second most common side effect 1
- Dry mouth (3%) 1
- Abdominal/gastric distress (2%) 1
- Diarrhea (2%) 1
- Constipation (1%) 1
- Vomiting (1%) 1
Other Common Effects
Discontinuation Rates
Approximately 10% of patients discontinued buspirone in premarketing trials due to adverse events 1. The primary reasons for discontinuation were:
- CNS disturbances (3.4%): primarily dizziness, insomnia, nervousness, drowsiness, and lightheadedness 1
- GI disturbances (1.2%): primarily nausea 1
- Miscellaneous (1.1%): primarily headache and fatigue 1
- Multiple complaints (3.4%) 1
Less Common but Clinically Important Side Effects
Cardiovascular (Infrequent to Rare)
- Syncope, hypotension, hypertension (infrequent) 1
- Cerebrovascular accident, congestive heart failure, myocardial infarction, cardiomyopathy, bradycardia (rare) 1
Neurological/Psychiatric (Infrequent to Rare)
- Dream disturbances (frequent) 1
- Depersonalization, dysphoria, euphoria, akathisia, hallucinations, involuntary movements (infrequent) 1
- Suicidal ideation and seizures (infrequent) 1
- Stupor, slurred speech, psychosis (rare) 1
Other Systems
- Sexual dysfunction: decreased or increased libido (infrequent), delayed ejaculation and impotence (rare) 1
- Hepatic: increases in aminotransferases (SGOT, SGPT) (infrequent) 1
- Hematologic: eosinophilia, leukopenia, thrombocytopenia (rare) 1
Postmarketing Reports
Additional adverse events reported since market introduction include 1:
- Allergic reactions (including urticaria) and angioedema
- Extrapyramidal symptoms: cogwheel rigidity, dystonic reactions, dyskinesias (acute and tardive), parkinsonism, akathisia, restless leg syndrome
- Serotonin syndrome
- Ataxias, vertigo
- Transient difficulty with recall
- Urinary retention
- Visual changes (including tunnel vision)
Important Clinical Considerations
Comparison to Benzodiazepines
Unlike benzodiazepines, buspirone 2, 3, 4:
- Lacks anticonvulsant and muscle-relaxant properties
- Causes minimal sedation
- Does not impair psychomotor function when combined with alcohol
- Has no reported abuse, dependence, or withdrawal symptoms
- Does not potentiate sedative-hypnotic drugs
Onset and Tolerability
- Buspirone may take 2-4 weeks to become effective for anxiety management 5
- The frequency of adverse effects is generally low 2
- Most side effects are mild and transient 2, 4
Common Pitfalls
- Previous benzodiazepine exposure: Patients with chronic benzodiazepine use may experience reduced efficacy and higher dropout rates with buspirone, particularly if unable to complete adequate washout periods 6
- Nausea and giddiness are the primary side effects leading to early discontinuation 6
- Starting doses should be low (5 mg twice daily) and titrated gradually to minimize side effects 5